Search Results
May 11, 2026, 08:00 ET Johnson & Johnson reinforces its leadership in advancing neuropsychiatry with new portfolio and pipeline data at APA and ASCP
https://www.nami.org/types-of-conditions/schizophrenia/Alphs L, et al. Factors associated with relapse in schizophrenia despite adherence to long-acting injectable therapy. Int Clin Psychopharmacol. 2016;31(4)202-209. doi:10.1097/YIC.0000000000000125Recourt K, de Boer P, Zuiker R, et al. The selective orexin-2 antagonist
More news about: Johnson & Johnson
May 07, 2026, 16:06 ET Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
leiomyosarcoma, liposarcoma, and undifferentiated pleomorphic sarcoma.About INT230-6INT230-6, Intensity's lead proprietary investigational product candidate, is designed for direct intratumoral injection. INT230-6 was discovered using Intensity's proprietary DfuseRx℠ technology platform.
More news about: Intensity Therapeutics Inc.
May 06, 2026, 00:00 ET Alebund Pharmaceuticals Announces Completion of Patient Enrollment in Global Phase III Pivotal Multi-Regional Clinical Trial of AP301 for Hyperphosphatemia
Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2017;7(1):1-59.[2]
More news about: Alebund Pharmaceuticals
May 05, 2026, 18:16 ET Multi-Stakeholder Expert Panel Finds UTI Management in the United States Represents a Solvable Systemic Failure Costing More Than $6 Billion Annually
L.K.S.; Wang, D.; Stapleton, A.E.; Lukacz, E.S. Microbial Threshold Guidelines for UTI Diagnosis: A Scoping Systematic Review. Pathol. Lab. Med. Int. 2023, 15, 43–63, doi:10.2147/PLMI.S409488.5 Festa, R.A.; Luke, N.; Mathur, M.; Parnell, L.; Wang, D.; Zhao, X.; Magallon, J.;
More news about: Pathnostics
May 05, 2026, 17:01 ET Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1
https://mhraproducts4853.blob.core.windows.net/docs/07df769800514385e1a35a9bacc554d590f6cf1b Accessed April 2026Meijer AJM, et al. Front Oncol 2024; 14: 1336714Tan WJT, Vlajkovic SM. Int J Mol Sci 2023; 24(22): 16545PEDMARQSI® Consumer Medicines Information (CMI):
More news about: Norgine
May 05, 2026, 17:01 ET Norgine begrüßt die TGA-Zulassung von PEDMARQSI® (Natriumthiosulfat wasserfrei) in Australien zur Vorbeugung von Cisplatin-induziertem Hörverlust bei Kindern1
https://mhraproducts4853.blob.core.windows.net/docs/07df769800514385e1a35a9bacc554d590f6cf1b Accessed April 2026Meijer AJM, et al. Front Oncol 2024; 14: 1336714Tan WJT, Vlajkovic SM. Int J Mol Sci 2023; 24(22): 16545PEDMARQSI® Arzneimittelinformationen für Verbraucher (CMI):
More news about: Norgine
May 05, 2026, 17:01 ET Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1
https://mhraproducts4853.blob.core.windows.net/docs/07df769800514385e1a35a9bacc554d590f6cf1b Accessed April 2026Meijer AJM, et al. Front Oncol 2024; 14: 1336714Tan WJT, Vlajkovic SM. Int J Mol Sci 2023; 24(22): 16545PEDMARQSI® Consumer Medicines Information (CMI):
More news about: Norgine
May 05, 2026, 17:01 ET Norgine celebra el registro de la TGA en Australia de PEDMARQSI®
https://mhraproducts4853.blob.core.windows.net/docs/07df769800514385e1a35a9bacc554d590f6cf1b Consultado en abril de 2026Meijer AJM, et al. Front Oncol 2024; 14: 1336714Tan WJT, Vlajkovic SM. Int J Mol Sci 2023; 24(22): 16545PEDMARQSI® Consumer Medicines Information (CMI):
More news about: Norgine
May 05, 2026, 17:01 ET Norgine se félicite de l'enregistrement par la TGA en Australie de PEDMARQSI® (thiosulfate de sodium anhydre) pour la prévention de la perte auditive induite par le cisplatine chez les enfants1
https://mhraproducts4853.blob.core.windows.net/docs/07df769800514385e1a35a9bacc554d590f6cf1b Accessed April 2026Meijer AJM, et al. Front Oncol 2024 ; 14 : 1336714Tan WJT, Vlajkovic SM. Int J Mol Sci 2023 ; 24(22) : 16545PEDMARQSI® Information sur les médicaments à l'intention des consommateurs (CMI) :
More news about: Norgine
May 05, 2026, 11:21 ET The Latest Research Supports Massage Therapy for Muscle Recovery and Athletic Performance
[email protected] Citations:Arsovski D. Deep Tissue Massage Therapy: Effects on Muscle Recovery and Performance in Athletes. Int J Ther Massage Bodywork. 2025 Jun 12;18(2):40-51. doi: 10.3822/ijtmb.v18i2.1139. PMID: 40510040; PMCID: PMC12140169.Wei
More news about: American Massage Therapy Association
Apr 30, 2026, 08:30 ET Wellspect HealthCare Expands Surity™ Portfolio in the U.S. with Surity™ Male External Catheter for Urinary Incontinence Care
from: https://nafc\.org/bhealth\-blog/the\-true\-impact\-of\-incontinence/ Cheng S, Lin D, Hu T, et al. Association of urinary incontinence and depression or anxiety: a meta‑analysis. J Int Med Res. 2020;48(6):0300060520931348. Family Caregiver Alliance. Caring for someone with incontinence: emotional and
More news about: Wellspect HealthCare
Apr 30, 2026, 08:30 ET CW Bancorp Reports First Quarter 2026 EPS of $1.18, up 22%
Int Bearing Due from Banks & FFS$
More news about: CW Bancorp
Apr 30, 2026, 00:00 ET 推動全球食品革命：日本尖端食品加工技術表現突出
時間：2026年6月2日至5日，上午10點至下午5點地點：日本東京Big Sight國際展示中心組織者：日本食品機械工業會(FOOMA)官方網站：https://www.foomajapan.jp/int/官方網絡雜誌：https://foomajapanplus.jp/日本國際食品工業展社交媒體：
More news about: FOOMA JAPAN
Apr 30, 2026, 00:00 ET 글로벌 식품 혁명 주도: 일본의 최첨단 식품 가공 기술이 중심 무대에
사이트주최: 일본 식품기계 박람회(푸마)공식 웹사이트: https://www.foomajapan.jp/int/ 공식 웹 매거진: https://foomajapanplus.jp/ 푸마
More news about: FOOMA JAPAN
Apr 30, 2026, 00:00 ET Dorong Revolusi Pangan Global, Teknologi "Food Processing" Jepang Tampil di Panggung Dunia
Manufacturers' Association (FOOMA)Situs resmi: https://www.foomajapan.jp/int/ Web Magazine: https://foomajapanplus.jp/Akun
More news about: FOOMA JAPAN
Apr 30, 2026, 00:00 ET Driving the Global Food Revolution: Japan's Cutting-Edge Food Processing Technology Takes Center Stage
Manufacturers' Association (FOOMA)Official Website: https://www.foomajapan.jp/int/ Official Web Magazine: https://foomajapanplus.jp/FOOMA
More news about: FOOMA JAPAN
Apr 30, 2026, 00:00 ET वैश्विक खाद्य क्रांति को आगे बढ़ाना: जापान की अत्याधुनिक खाद्य प्रोसेसिंग टेक्नोलॉजी ने प्रमुख स्थान प्राप्त किया
Manufacturers' Association (FOOMA)आधिकारिक वेबसाइट: https://www.foomajapan.jp/int/ आधिकारिक वेब पत्रिका: https://foomajapanplus.jp/FOOMA
More news about: FOOMA JAPAN
Apr 30, 2026, 00:00 ET Thúc đẩy cuộc cách mạng thực phẩm toàn cầu: Công nghệ chế biến thực phẩm tiên tiến của Nhật Bản giữ vai trò trung tâm
Thực phẩm Nhật Bản (FOOMA)Trang web chính thức: https://www.foomajapan.jp/int/ Tạp chí Web chính thức: https://foomajapanplus.jp/Mạng
More news about: FOOMA JAPAN
Apr 27, 2026, 08:00 ET FDA approves CAPLYTA® (lumateperone) sNDA with robust new data supporting reduced risk of relapse in schizophrenia
developments.Footnotesi Alphs L, et al. Factors associated with relapse in schizophrenia despite adherence to long-acting injectable therapy. Int Clin Psychopharmacol. 2016;31(4)202-209. doi:10.1097/YIC.0000000000000125ii "Schizophrenia Fact Sheet." Treatment Advocacy Center,
More news about: Johnson & Johnson
Apr 24, 2026, 06:00 ET Guerbet annonce une étape majeure dans l'indication « embolisation vasculaire » pour Lipiodol® Ultra Fluid (Esters éthyliques d'acides gras iodés de l'huile d'œillette)
Berlien HP, et al. Consensus Document of the International Union of Angiology (IUA)-2013. Current concept on the management of arterio-venous management. Int Angiol. 2013;32(1):9-36.Logo - https://mma.prnewswire.com/media/2870473/5928522/Guerbet_Logo.jpg
More news about: Guerbet
Apr 22, 2026, 09:00 ET First Community Corporation Announces First Quarter Results and Cash Dividend
Int bearing deposits in other banks205,972
More news about: First Community Corporation
Apr 21, 2026, 10:50 ET A linha aprimorada de criptomoedas da Axi alcança uma taxa de adoção de 46% em seu portfólio entre os clientes
https://www.axi.com/int/blog/education/cryptocurrencies/spot-trading-cryptocurrencySobre a AxiA Axi é uma marca global de trading de FX e CFD on-line, atendendo milhares
More news about: AxiTrader
Apr 21, 2026, 10:49 ET La gama mejorada de criptomonedas de Axi logra una adopción del 46% en las carteras de sus clientes
https://www.axi.com/int/blog/education/cryptocurrencies/spot-trading-cryptocurrencyAcerca de AxiAxi es una marca global de trading online de divisas
More news about: AxiTrader
Apr 21, 2026, 10:44 ET Das erweiterte Krypto-Angebot von Axi verzeichnet eine Portfolio-Akzeptanz von 46 % bei den Kunden
https://www.axi.com/int/blog/education/cryptocurrencies/spot-trading-cryptocurrencyInformationen zu AxiAxi ist eine globale Online-FX- und CFD-Handelsmarke, die Tausende
More news about: AxiTrader
Apr 21, 2026, 10:41 ET La gamme améliorée de cryptos d'Axi permet une adoption à 46 % chez sa clientèle
https://www.axi.com/int/blog/education/cryptocurrencies/spot-trading-cryptocurrencyÀ propos d'AxiAxi est une marque mondiale de trading en ligne pour les devises et les CFD,
More news about: AxiTrader